KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $314,000 | -10.3% | 30,807 | -7.5% | 0.00% | 0.0% |
| Q1 2021 | $350,000 | -34.2% | 33,299 | -4.1% | 0.00% | 0.0% |
| Q4 2020 | $532,000 | +3.3% | 34,705 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $515,000 | -25.5% | 35,383 | -3.1% | 0.00% | -50.0% |
| Q2 2020 | $691,000 | -36.3% | 36,531 | -35.4% | 0.00% | -50.0% |
| Q1 2020 | $1,084,000 | +18.0% | 56,546 | +17.9% | 0.00% | +33.3% |
| Q4 2019 | $919,000 | +447.0% | 47,972 | +174.4% | 0.00% | – |
| Q3 2019 | $168,000 | – | 17,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |